1. Home
  2. DBI vs XGN Comparison

DBI vs XGN Comparison

Compare DBI & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Designer Brands Inc.

DBI

Designer Brands Inc.

HOLD

Current Price

$7.69

Market Cap

138.7M

ML Signal

HOLD

Logo Exagen Inc.

XGN

Exagen Inc.

HOLD

Current Price

$4.52

Market Cap

138.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DBI
XGN
Founded
1991
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
138.7M
138.0M
IPO Year
1991
2019

Fundamental Metrics

Financial Performance
Metric
DBI
XGN
Price
$7.69
$4.52
Analyst Decision
Hold
Strong Buy
Analyst Count
2
6
Target Price
$7.25
$13.67
AVG Volume (30 Days)
1.0M
546.8K
Earning Date
12-09-2025
03-10-2026
Dividend Yield
2.58%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,892,654,000.00
$63,599,000.00
Revenue This Year
N/A
$21.40
Revenue Next Year
$2.87
$14.82
P/E Ratio
N/A
N/A
Revenue Growth
N/A
14.08
52 Week Low
$2.18
$2.67
52 Week High
$8.75
$12.23

Technical Indicators

Market Signals
Indicator
DBI
XGN
Relative Strength Index (RSI) 56.81 19.00
Support Level $7.18 $4.75
Resistance Level $7.85 $6.75
Average True Range (ATR) 0.53 0.42
MACD -0.12 -0.08
Stochastic Oscillator 56.30 1.40

Price Performance

Historical Comparison
DBI
XGN

About DBI Designer Brands Inc.

Designer Brands Inc is a designer, producer, and retailer of footwear and accessories. The company operates in three reportable segments: the U.S. Retail segment, the Canada Retail segment and the Brand Portfolio segment. The U.S. Retail segment operates the DSW Designer Shoe Warehouse banner through its direct-to-consumer U.S. stores and e-commerce site. The Canada Retail segment operates The Shoe Company and DSW banners through its direct-to-consumer Canada stores and e-commerce sites. The Brand Portfolio segment earns revenue from the sale of wholesale products to retailers, commissions for serving retailers as the design and buying agent for products under private labels, and the sale of branded products through its direct-to-consumer e-commerce sites.

About XGN Exagen Inc.

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.

Share on Social Networks: